Rational Design, Synthesis, Biophysical and Antiproliferative Evaluation of Fluorenone Derivatives with DNA G‐Quadruplex Binding Properties
暂无分享,去创建一个
Stefano Alcaro | Anna Artese | Lucia Parrotta | Francesco Ortuso | Sotiris Missailidis | Francesco Paduano | Claudia Sissi | Francesco Trapasso | F. Paduano | F. Trapasso | S. Alcaro | S. Missailidis | A. Artese | L. Parrotta | F. Ortuso | C. Sissi | J. Iley | M. Vigorita | R. Pasceri | James N. Iley | Raffaele Pasceri | Maria Gabriella Vigorita
[1] Stephen Neidle,et al. Crystal structure of parallel quadruplexes from human telomeric DNA , 2002, Nature.
[2] Roger A. Jones,et al. Structure of the Hybrid-2 type intramolecular human telomeric G-quadruplex in K+ solution: insights into structure polymorphism of the human telomeric sequence , 2007, Nucleic acids research.
[3] R. Wellinger,et al. The terminal DNA structure of mammalian chromosomes , 1997, The EMBO journal.
[4] T. Creighton. Methods in Enzymology , 1968, The Yale Journal of Biology and Medicine.
[5] M. Stevens,et al. Potent inhibition of telomerase by small-molecule pentacyclic acridines capable of interacting with G-quadruplexes. , 2001, Molecular pharmacology.
[6] Sarah W. Burge,et al. Quadruplex DNA: sequence, topology and structure , 2006, Nucleic acids research.
[7] D. Sun,et al. G-quadruplex DNA binding by a series of carbocyanine dyes. , 2001, Bioorganic & medicinal chemistry letters.
[8] K. Dubrana,et al. Telomeres and telomerase as targets for anticancer drug development. , 2006, Critical reviews in oncology/hematology.
[9] W. Delano. The PyMOL Molecular Graphics System (2002) , 2002 .
[10] D. Patel,et al. Solution structure of the human telomeric repeat d[AG3(T2AG3)3] G-tetraplex. , 1993, Structure.
[11] B. Guyen,et al. Synthesis and evaluation of analogues of 10H-indolo[3,2-b]quinoline as G-quadruplex stabilising ligands and potential inhibitors of the enzyme telomerase. , 2004, Organic & biomolecular chemistry.
[12] S. Alcaro,et al. Tetraplex DNA specific ligands based on the fluorenone-carboxamide scaffold. , 2007, Bioorganic & medicinal chemistry letters.
[13] S. Alcaro,et al. 9-Fluorenon-4-carboxamides: synthesis, conformational analysis, anti-HSV-2, and immunomodulatory evaluation. Note II , 2004 .
[14] Stephen Neidle,et al. The structures of quadruplex nucleic acids and their drug complexes. , 2009, Current opinion in structural biology.
[15] S. Neidle,et al. Structure-based design of benzylamino-acridine compounds as G-quadruplex DNA telomere targeting agents. , 2007, Bioorganic & medicinal chemistry letters.
[16] Jean-Louis Mergny,et al. Targeting telomeres and telomerase. , 2008, Biochimie.
[17] W. Delano. The PyMOL Molecular Graphics System , 2002 .
[18] S. Neidle,et al. 2,7-Disubstituted amidofluorenone derivatives as inhibitors of human telomerase. , 1999, Journal of medicinal chemistry.
[19] B. Gatto,et al. Perylene side chains modulate G-quadruplex conformation in biologically relevant DNA sequences. , 2008, Bioorganic & medicinal chemistry.
[20] Stefano Alcaro,et al. A “quasi‐flexible” automatic docking processing for studying stereoselective recognition mechanisms. Part I. Protocol validation , 2000 .
[21] Roger A. Jones,et al. Structure of the intramolecular human telomeric G-quadruplex in potassium solution: a novel adenine triple formation , 2007, Nucleic acids research.
[22] T. Mosmann. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. , 1983, Journal of immunological methods.
[23] David S. Goodsell,et al. Automated docking using a Lamarckian genetic algorithm and an empirical binding free energy function , 1998 .
[24] Marco Pierini,et al. “Quasi flexible” automatic docking processing for studying stereoselective recognition mechanisms, part 2: Prediction of ΔΔG of complexation and 1H‐NMR NOE correlation , 2007, J. Comput. Chem..
[25] M. Caraglia,et al. The multidrug transporter P-glycoprotein: a mediator of melanoma invasion? , 2008, The Journal of investigative dermatology.
[26] S. Mackay,et al. Molecular modelling and cytotoxicity of substituted anthraquinones as inhibitors of human telomerase. , 2002, Bioorganic & medicinal chemistry.
[27] Charles A Laughton,et al. Antitumor polycyclic acridines. 8.(1) Synthesis and telomerase-inhibitory activity of methylated pentacyclic acridinium salts. , 2002, Journal of medicinal chemistry.
[28] Stephen Neidle,et al. Structure-based design of selective and potent G quadruplex-mediated telomerase inhibitors , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[29] S. Neidle,et al. 1,4- and 2,6-disubstituted amidoanthracene-9,10-dione derivatives as inhibitors of human telomerase. , 1998, Journal of medicinal chemistry.
[30] L. Kèlland,et al. Overcoming the immortality of tumour cells by telomere and telomerase based cancer therapeutics--current status and future prospects. , 2005, European journal of cancer.
[31] S. Neidle,et al. Natural and synthetic G-quadruplex interactive berberine derivatives. , 2006, Bioorganic & medicinal chemistry letters.
[32] Stefano Alcaro,et al. GRID‐based Pharmacophore Models: Concept and Application Examples , 2006 .
[33] Anna Artese,et al. Rational Approaches to Anticancer Drug Design/in silico Drug Development , 2008 .
[34] O. Fedoroff,et al. NMR-Based model of a telomerase-inhibiting compound bound to G-quadruplex DNA. , 1998, Biochemistry.
[35] A. Phan,et al. Structure of two intramolecular G-quadruplexes formed by natural human telomere sequences in K+ solution† , 2007, Nucleic acids research.
[36] P. Lord,et al. A Strategy for Primary High Throughput Cytotoxicity Screening in Pharmaceutical Toxicology , 2000, Pharmaceutical Research.
[37] P J Goodford,et al. A search for specificity in DNA-drug interactions. , 1994, Journal of Molecular Graphics.
[38] W. C. Still,et al. Semianalytical treatment of solvation for molecular mechanics and dynamics , 1990 .
[39] J. Mergny,et al. Cell senescence and telomere shortening induced by a new series of specific G-quadruplex DNA ligands , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[40] R. Wheelhouse,et al. Quadruplex-interactive agents as telomerase inhibitors: synthesis of porphyrins and structure-activity relationship for the inhibition of telomerase. , 2001, Journal of medicinal chemistry.
[41] G. Chang,et al. Macromodel—an integrated software system for modeling organic and bioorganic molecules using molecular mechanics , 1990 .
[42] J. Chaires,et al. The tail of the telomere. , 2008, Journal of the American Chemical Society.
[43] P. Goodford. A computational procedure for determining energetically favorable binding sites on biologically important macromolecules. , 1985, Journal of medicinal chemistry.
[44] E. De Pauw,et al. Selective interaction of ethidium derivatives with quadruplexes: an equilibrium dialysis and electrospray ionization mass spectrometry analysis. , 2003, Biochemistry.
[45] S. Neidle,et al. Design, synthesis and evaluation of human telomerase inhibitors based upon a tetracyclic structural motif. , 1999, Anti-cancer drug design.
[46] Dik-Lung Ma,et al. 5-N-methylated quindoline derivatives as telomeric g-quadruplex stabilizing ligands: effects of 5-N positive charge on quadruplex binding affinity and cell proliferation. , 2008, Journal of medicinal chemistry.